Table 2.
First Author HRR |
Other Author HRR |
Author HRR for Different Drug |
HRR with No Authors |
|
---|---|---|---|---|
Variables | (1) | (2) | (3) | (4) |
Drug utilization rate | 0.156 | 0.097 | 0.092 | 0.086 |
Fraction treated in author’s group | 0.534 | 0.357 | 0.000 | 0.000 |
Number of observations | 6,985 | 29,322 | 250,330 | 372,831 |
Average number of patients per HRR per drug | 388 | 236 | 254 | 75 |
Number of HRR-drug pairs | 18 | 124 | 986 | 4958 |
Number of unique HRRs | 11 | 54 | 54 | 252 |
Regions are defined by the 306 Dartmouth Atlas Hospital Referral Regions (HRRs). For each drug in the sample, regions are partitioned into four groups based on geographic proximity to authors of the pivotal trial, corresponding to the four columns in the table. Statistics are then reported for each column by aggregating over the set of drugs in the sample. Reported statistics reflect drug utilization over the first two years following initial introduction. Data on drug utilization come from Medicare claims, 1998–2008.